British investigators take a long-range view of tumor necrosis factor inhibitors in patients with psoriatic arthritis.
An expanded role for MRI and 2 recently approved treatment options.
Menopause, obesity, and bacterial infection all have a negative impact on RA, according to 3 recent studies.
What does compensation for rheumatologists look like these days? Would you choose rheumatology all over again? Here: key highlights from the Medscape Rheumatologist Compensation Report.
An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis
Norwegian researchers looked at the long-term prevalence of inflammatory back disorders in patients with IBD—and identified a predisposing factor.
Highlights of 5 topline news stories from the FDA, CDC, and American College of Rheumatology—with real-world implications for primary care practice.
To paraphrase Winston Churchill, rarely have so few been called upon by so many.
We looked back to find out what you found most interesting this past year. Here are links and a quick recap.
Here’s a brief look at medications for rheumatologic disorders that were newly approved in the last quarter of 2017.